Associations of immunological factors with metabolic syndrome and its characteristic elements in Chinese centenarians

[1]  S. Fu,et al.  Prevalence of metabolic syndrome risk factors and their relationships with renal function in Chinese centenarians , 2018, Scientific Reports.

[2]  Xiaoying Li,et al.  Cohort Profile: The China Hainan Centenarian Cohort Study (CHCCS). , 2018, International journal of epidemiology.

[3]  M. Qorbani,et al.  Association of serum complement C3 with metabolic syndrome components in normal weight obese women , 2017, Journal of Diabetes & Metabolic Disorders.

[4]  Zhen Wang,et al.  Mast cell specific immunological biomarkers and metabolic syndrome among middle-aged and older Chinese adults. , 2017, Endocrine journal.

[5]  G. Ning,et al.  Consensus on the Prevention of Type 2 Diabetes in Chinese Adults , 2017, Chinese medical journal.

[6]  P. Sebastiani,et al.  Compression of Morbidity Is Observed Across Cohorts with Exceptional Longevity , 2016, Journal of the American Geriatrics Society.

[7]  D. Panagiotakos,et al.  Metabolic syndrome and 10-year cardiovascular disease incidence: The ATTICA study. , 2016, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[8]  D. Jopp,et al.  Physical, cognitive, social and mental health in near-centenarians and centenarians living in New York City: findings from the Fordham Centenarian Study , 2016, BMC Geriatrics.

[9]  Z. Mo,et al.  Elevated serum complement factors 3 and 4 are strong inflammatory markers of the metabolic syndrome development: a longitudinal cohort study , 2016, Scientific Reports.

[10]  J. Shapiro,et al.  Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population , 2016, International journal of medical sciences.

[11]  R. Wong,et al.  Prevalence of the metabolic syndrome in the United States, 2003-2012. , 2015, JAMA.

[12]  J. Bressan,et al.  Prevalence of metabolic syndrome and pre-metabolic syndrome in health professionals: LATINMETS Brazil study , 2015, Diabetology & Metabolic Syndrome.

[13]  B. Nilsson,et al.  C3 and C4 are strongly related to adipose tissue variables and cardiovascular risk factors , 2014, European journal of clinical investigation.

[14]  Jaspinder Kaur.  A Comprehensive Review on Metabolic Syndrome , 2014, Cardiology research and practice.

[15]  B. Li,et al.  Immunoglobulin E and mast cell proteases are potential risk factors of impaired fasting glucose and impaired glucose tolerance in humans , 2013, Annals of medicine.

[16]  John D Lambris,et al.  The role of the complement system in metabolic organs and metabolic diseases. , 2013, Seminars in immunology.

[17]  S. Hercberg,et al.  Dietary fat, abdominal obesity and smoking modulate the relationship between plasma complement component 3 concentrations and metabolic syndrome risk. , 2012, Atherosclerosis.

[18]  P. Libby,et al.  IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe-/- mice. , 2011, The Journal of clinical investigation.

[19]  G. Can,et al.  Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population. , 2010, Metabolism: clinical and experimental.

[20]  S. Bryssine,et al.  [The prevalence of metabolic syndrome]. , 2010, Soins. Psychiatrie.

[21]  J. Martínez,et al.  Selenium intake reduces serum C3, an early marker of metabolic syndrome manifestations, in healthy young adults , 2009, European Journal of Clinical Nutrition.

[22]  K. Clément,et al.  Deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice , 2009, Nature Medicine.

[23]  K. Cianflone,et al.  Acylation stimulating protein but not complement C3 associates with metabolic syndrome components in Chinese children and adolescents. , 2008, European journal of endocrinology.

[24]  A. Marcos,et al.  Low-grade inflammation and the metabolic syndrome in children and adolescents , 2008, Current opinion in lipidology.

[25]  M. Zoli,et al.  Serum C3 Is a Stronger Inflammatory Marker of Insulin Resistance Than C-Reactive Protein, Leukocyte Count, and Erythrocyte Sedimentation Rate , 2007, Diabetes Care.

[26]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[27]  S. Grundy,et al.  The metabolic syndrome. , 2008, Endocrine reviews.

[28]  Fernando Costa,et al.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. , 2005, Circulation.

[29]  R. Krauss,et al.  Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. , 2005, Cardiology in review.

[30]  Paul Zimmet,et al.  The metabolic syndrome—a new worldwide definition , 2005, The Lancet.

[31]  M. Malaguarnera,et al.  Successful aging in centenarians: myths and reality. , 2005, Archives of gerontology and geriatrics.

[32]  Zhi-xian Gao,et al.  Differentiation of rat neural stem cells and its relationship with environment. , 2004, Biomedical and environmental sciences : BES.

[33]  L. Lönn,et al.  High expression of complement components in omental adipose tissue in obese men. , 2003, Obesity research.

[34]  T. Perls,et al.  Morbidity profiles of centenarians: survivors, delayers, and escapers. , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.

[35]  A. Marette.  Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings , 2002, Current opinion in clinical nutrition and metabolic care.

[36]  P. Puddu,et al.  Different associations of C-reactive protein, fibrinogen and C3 with traditional risk factors in middle-aged men. , 2002, International journal of cardiology.

[37]  W. Dietz,et al.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.

[38]  John D Lambris,et al.  Phylogenetic aspects of the complement system. , 2001, Developmental and comparative immunology.

[39]  A. Astrup,et al.  Obesity : Preventing and managing the global epidemic , 2000 .

[40]  C. Martignani,et al.  Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men. , 2000, European heart journal.

[41]  R. Pratley,et al.  Insulin action and insulinemia are closely related to the fasting complement C3, but not acylation stimulating protein concentration. , 2000, Diabetes care.

[42]  P. Kovanen,et al.  Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M. , 1998, Archives of internal medicine.

[43]  J. Gauldie,et al.  The acute phase response. , 1994, Immunology today.

[44]  K. Cianflone,et al.  Coordinate regulation of triacylglycerol synthesis and glucose transport by acylation-stimulating protein. , 1993, Metabolism: clinical and experimental.

[45]  B. Spiegelman,et al.  Adipsin and an endogenous pathway of complement from adipose cells. , 1992, The Journal of biological chemistry.

[46]  K. Cianflone,et al.  Impaired response of fibroblasts from patients with hyperapobetalipoproteinemia to acylation-stimulating protein. , 1990, The Journal of clinical investigation.

[47]  [Chinese guidelines on prevention and treatment of dyslipidemia in adults]. , 2007, Zhonghua xin xue guan bing za zhi.

[48]  F. Lu,et al.  The guidelines for prevention and control of overweight and obesity in Chinese adults. , 2004, Biomedical and environmental sciences : BES.

[49]  Who Consultation on Obesity.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation. , 2000, World Health Organization technical report series.